These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
150 related articles for article (PubMed ID: 27391793)
1. lincRNA-p21 inhibits invasion and metastasis of hepatocellular carcinoma through Notch signaling-induced epithelial-mesenchymal transition. Jia M; Jiang L; Wang YD; Huang JZ; Yu M; Xue HZ Hepatol Res; 2016 Oct; 46(11):1137-1144. PubMed ID: 27391793 [TBL] [Abstract][Full Text] [Related]
2. LincRNA-p21 inhibits invasion and metastasis of hepatocellular carcinoma through miR-9/E-cadherin cascade signaling pathway molecular mechanism. Ding G; Peng Z; Shang J; Kang Y; Ning H; Mao C Onco Targets Ther; 2017; 10():3241-3247. PubMed ID: 28721075 [TBL] [Abstract][Full Text] [Related]
3. LincRNA-p21 activates endoplasmic reticulum stress and inhibits hepatocellular carcinoma. Yang N; Fu Y; Zhang H; Sima H; Zhu N; Yang G Oncotarget; 2015 Sep; 6(29):28151-63. PubMed ID: 26305675 [TBL] [Abstract][Full Text] [Related]
4. FoxM1 overexpression promotes epithelial-mesenchymal transition and metastasis of hepatocellular carcinoma. Meng FD; Wei JC; Qu K; Wang ZX; Wu QF; Tai MH; Liu HC; Zhang RY; Liu C World J Gastroenterol; 2015 Jan; 21(1):196-213. PubMed ID: 25574092 [TBL] [Abstract][Full Text] [Related]
5. Novel ADAM-17 inhibitor ZLDI-8 inhibits the metastasis of hepatocellular carcinoma by reversing epithelial-mesenchymal transition in vitro and in vivo. Lu HY; Chu HX; Tan YX; Qin XC; Liu MY; Li JD; Ren TS; Zhang YS; Zhao QC Life Sci; 2020 Mar; 244():117343. PubMed ID: 31978449 [TBL] [Abstract][Full Text] [Related]
6. [Long noncoding RNA UFC1 promotes metastasis and invasion of hepatocellular carcinoma cells Wang J; Cao C; Zeng Q; Dong Z Nan Fang Yi Ke Da Xue Xue Bao; 2019 Jun; 39(6):679-684. PubMed ID: 31270046 [TBL] [Abstract][Full Text] [Related]
7. Effects of knockout of lincRNA-p21 on the proliferation, migration and invasion ability of HepG2 liver cancer cells. Wang T; Liu J; Li S; Yuan Z; Huang X Oncol Lett; 2019 Jun; 17(6):5103-5107. PubMed ID: 31186722 [TBL] [Abstract][Full Text] [Related]
8. Suppressive effects of microRNA-16 on the proliferation, invasion and metastasis of hepatocellular carcinoma cells. Wu WL; Wang WY; Yao WQ; Li GD Int J Mol Med; 2015 Dec; 36(6):1713-9. PubMed ID: 26499886 [TBL] [Abstract][Full Text] [Related]
9. Down regulation of lincRNA-p21 contributes to gastric cancer development through Hippo-independent activation of YAP. Chen Y; Wei G; Xia H; Yu H; Tang Q; Bi F Oncotarget; 2017 Sep; 8(38):63813-63824. PubMed ID: 28969031 [TBL] [Abstract][Full Text] [Related]
10. Long Noncoding RNA AK021443 Promotes Cell Proliferation and Migration by Regulating Epithelial-Mesenchymal Transition in Hepatocellular Carcinoma Cells. Yang J; Li J; Liu B; Zhang R; Gu F; Zhao J; Cheng S DNA Cell Biol; 2018 May; 37(5):481-490. PubMed ID: 29638164 [TBL] [Abstract][Full Text] [Related]
11. Long noncoding RNA TPTE2P1 promotes the migration and invasion of hepatocellular carcinoma. Liu J; Wang Z; Yin Y; Li N; Ye NY; Bao B; Gu HC Eur Rev Med Pharmacol Sci; 2019 May; 23(9):3733-3741. PubMed ID: 31114999 [TBL] [Abstract][Full Text] [Related]
12. Long non-coding RNA CASC2 suppresses epithelial-mesenchymal transition of hepatocellular carcinoma cells through CASC2/miR-367/FBXW7 axis. Wang Y; Liu Z; Yao B; Li Q; Wang L; Wang C; Dou C; Xu M; Liu Q; Tu K Mol Cancer; 2017 Jul; 16(1):123. PubMed ID: 28716020 [TBL] [Abstract][Full Text] [Related]
13. TRIM66 promotes malignant progression of hepatocellular carcinoma by inhibiting E-cadherin expression through the EMT pathway. Zhang HG; Pan YW; Feng J; Zeng CT; Zhao XQ; Liang B; Zhang WW Eur Rev Med Pharmacol Sci; 2019 Mar; 23(5):2003-2012. PubMed ID: 30915743 [TBL] [Abstract][Full Text] [Related]
14. Role of IQGAP3 in metastasis and epithelial-mesenchymal transition in human hepatocellular carcinoma. Shi Y; Qin N; Zhou Q; Chen Y; Huang S; Chen B; Shen G; Jia H J Transl Med; 2017 Aug; 15(1):176. PubMed ID: 28810875 [TBL] [Abstract][Full Text] [Related]
15. MCUR1 facilitates epithelial-mesenchymal transition and metastasis via the mitochondrial calcium dependent ROS/Nrf2/Notch pathway in hepatocellular carcinoma. Jin M; Wang J; Ji X; Cao H; Zhu J; Chen Y; Yang J; Zhao Z; Ren T; Xing J J Exp Clin Cancer Res; 2019 Mar; 38(1):136. PubMed ID: 30909929 [TBL] [Abstract][Full Text] [Related]
16. HCRP1 downregulation promotes hepatocellular carcinoma cell migration and invasion through the induction of EGFR activation and epithelial-mesenchymal transition. Xu J; Zhang X; Wang H; Ge S; Gao T; Song L; Wang X; Li H; Qin Y; Zhang Z Biomed Pharmacother; 2017 Apr; 88():421-429. PubMed ID: 28122307 [TBL] [Abstract][Full Text] [Related]
17. Zhang Y; Miao Y; Shang M; Liu M; Liu R; Pan E; Pu Y; Yin L Cancer Manag Res; 2019; 11():6201-6214. PubMed ID: 31308755 [No Abstract] [Full Text] [Related]
18. EDIL3 is a novel regulator of epithelial-mesenchymal transition controlling early recurrence of hepatocellular carcinoma. Xia H; Chen J; Shi M; Gao H; Sekar K; Seshachalam VP; Ooi LL; Hui KM J Hepatol; 2015 Oct; 63(4):863-73. PubMed ID: 25980764 [TBL] [Abstract][Full Text] [Related]
19. GP73 promotes epithelial-mesenchymal transition and invasion partly by activating TGF-β1/Smad2 signaling in hepatocellular carcinoma. Yang Y; Liu Q; Li Z; Zhang R; Jia C; Yang Z; Zhao H; Ya S; Mao R; Ailijiang T; Bao Y; Zhang H Carcinogenesis; 2018 Jul; 39(7):900-910. PubMed ID: 29365054 [TBL] [Abstract][Full Text] [Related]
20. MAP4K4 promotes epithelial-mesenchymal transition and metastasis in hepatocellular carcinoma. Feng XJ; Pan Q; Wang SM; Pan YC; Wang Q; Zhang HH; Zhu MH; Zhang SH Tumour Biol; 2016 Aug; 37(8):11457-67. PubMed ID: 27010469 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]